TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 87 filers reported holding TRANSENTERIX INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $70,000 | -48.1% | 113,695 | +13.7% | 0.00% | – |
| Q2 2019 | $135,000 | -47.1% | 99,999 | -6.9% | 0.00% | – |
| Q1 2019 | $255,000 | +28.1% | 107,369 | +21.9% | 0.00% | – |
| Q4 2018 | $199,000 | -89.3% | 88,089 | -72.5% | 0.00% | -100.0% |
| Q3 2018 | $1,861,000 | +963.4% | 320,847 | +698.9% | 0.00% | – |
| Q2 2018 | $175,000 | +307.0% | 40,163 | +59.4% | 0.00% | – |
| Q1 2018 | $43,000 | -97.5% | 25,192 | -97.9% | 0.00% | -100.0% |
| Q3 2017 | $1,717,000 | +100.4% | 1,200,667 | -0.6% | 0.00% | +100.0% |
| Q2 2017 | $857,000 | +3196.2% | 1,207,462 | +5552.6% | 0.00% | – |
| Q1 2017 | $26,000 | -45.8% | 21,361 | -42.9% | 0.00% | – |
| Q4 2016 | $48,000 | -21.3% | 37,434 | +3.0% | 0.00% | – |
| Q3 2016 | $61,000 | -16.4% | 36,361 | -39.9% | 0.00% | – |
| Q2 2016 | $73,000 | -27.7% | 60,520 | +153.9% | 0.00% | – |
| Q1 2016 | $101,000 | +260.7% | 23,839 | +89.8% | 0.00% | – |
| Q3 2015 | $28,000 | – | 12,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
| StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
| Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
| Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
| BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
| ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |